132 related articles for article (PubMed ID: 24948119)
1. Alzheimer's disease: Aβ-fibrinogen interaction inhibitor improves cognition in AD.
Flemming A
Nat Rev Drug Discov; 2014 Jul; 13(7):494. PubMed ID: 24948119
[No Abstract] [Full Text] [Related]
2. A novel Aβ-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer's disease mice.
Ahn HJ; Glickman JF; Poon KL; Zamolodchikov D; Jno-Charles OC; Norris EH; Strickland S
J Exp Med; 2014 Jun; 211(6):1049-62. PubMed ID: 24821909
[TBL] [Abstract][Full Text] [Related]
3. Aminopyrimidine Class Aggregation Inhibitor Effectively Blocks Aβ-Fibrinogen Interaction and Aβ-Induced Contact System Activation.
Singh PK; Kawasaki M; Berk-Rauch HE; Nishida G; Yamasaki T; Foley MA; Norris EH; Strickland S; Aso K; Ahn HJ
Biochemistry; 2018 Feb; 57(8):1399-1409. PubMed ID: 29394041
[TBL] [Abstract][Full Text] [Related]
4. PDE9A inhibition rescues amyloid beta-induced deficits in synaptic plasticity and cognition.
Kroker KS; Mathis C; Marti A; Cassel JC; Rosenbrock H; Dorner-Ciossek C
Neurobiol Aging; 2014 Sep; 35(9):2072-8. PubMed ID: 24746365
[TBL] [Abstract][Full Text] [Related]
5. A small molecule that displays marked reactivity toward copper- versus zinc-amyloid-β implicated in Alzheimer's disease.
Savelieff MG; Liu Y; Senthamarai RR; Korshavn KJ; Lee HJ; Ramamoorthy A; Lim MH
Chem Commun (Camb); 2014 May; 50(40):5301-3. PubMed ID: 24326305
[TBL] [Abstract][Full Text] [Related]
6. Lecanemab blocks the effects of the Aβ/fibrinogen complex on blood clots and synapse toxicity in organotypic culture.
Singh PK; Simões-Pires EN; Chen ZL; Torrente D; Calvano M; Sharma A; Strickland S; Norris EH
Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2314450121. PubMed ID: 38621133
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease peptide beta-amyloid interacts with fibrinogen and induces its oligomerization.
Ahn HJ; Zamolodchikov D; Cortes-Canteli M; Norris EH; Glickman JF; Strickland S
Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21812-7. PubMed ID: 21098282
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease.
Cortes-Canteli M; Paul J; Norris EH; Bronstein R; Ahn HJ; Zamolodchikov D; Bhuvanendran S; Fenz KM; Strickland S
Neuron; 2010 Jun; 66(5):695-709. PubMed ID: 20547128
[TBL] [Abstract][Full Text] [Related]
9. Anthocyanin suppresses the toxicity of Aβ deposits through diversion of molecular forms in in vitro and in vivo models of Alzheimer's disease.
Yamakawa MY; Uchino K; Watanabe Y; Adachi T; Nakanishi M; Ichino H; Hongo K; Mizobata T; Kobayashi S; Nakashima K; Kawata Y
Nutr Neurosci; 2016; 19(1):32-42. PubMed ID: 26304685
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of amyloid-β aggregation in Alzheimer's disease.
Wang Q; Yu X; Li L; Zheng J
Curr Pharm Des; 2014; 20(8):1223-43. PubMed ID: 23713775
[TBL] [Abstract][Full Text] [Related]
11. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L
Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
[TBL] [Abstract][Full Text] [Related]
12. Regulation of extracellular Zn(2+) homeostasis in the hippocampus as a therapeutic target for Alzheimer's disease.
Takeda A; Tamano H
Expert Opin Ther Targets; 2015; 19(8):1051-8. PubMed ID: 25818846
[TBL] [Abstract][Full Text] [Related]
13. Medicinal Chemistry Focusing on Aggregation of Amyloid-β.
Sohma Y
Chem Pharm Bull (Tokyo); 2016; 64(1):1-7. PubMed ID: 26726739
[TBL] [Abstract][Full Text] [Related]
14. Fibrin deposited in the Alzheimer's disease brain promotes neuronal degeneration.
Cortes-Canteli M; Mattei L; Richards AT; Norris EH; Strickland S
Neurobiol Aging; 2015 Feb; 36(2):608-17. PubMed ID: 25475538
[TBL] [Abstract][Full Text] [Related]
15. Brilliant Blue G improves cognition in an animal model of Alzheimer's disease and inhibits amyloid-β-induced loss of filopodia and dendrite spines in hippocampal neurons.
Chen X; Hu J; Jiang L; Xu S; Zheng B; Wang C; Zhang J; Wei X; Chang L; Wang Q
Neuroscience; 2014 Oct; 279():94-101. PubMed ID: 25193238
[TBL] [Abstract][Full Text] [Related]
16. SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease.
Brunner D; Flunkert S; Neddens J; Duller S; Scopes DIC; Treherne JM; Hutter-Paier B
Neurosci Lett; 2017 Nov; 660():96-102. PubMed ID: 28917978
[TBL] [Abstract][Full Text] [Related]
17. Structure-mechanism-based engineering of chemical regulators targeting distinct pathological factors in Alzheimer's disease.
Beck MW; Derrick JS; Kerr RA; Oh SB; Cho WJ; Lee SJ; Ji Y; Han J; Tehrani ZA; Suh N; Kim S; Larsen SD; Kim KS; Lee JY; Ruotolo BT; Lim MH
Nat Commun; 2016 Oct; 7():13115. PubMed ID: 27734843
[TBL] [Abstract][Full Text] [Related]
18. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
[TBL] [Abstract][Full Text] [Related]
19. Combining an amyloid-beta (Aβ) cleaving enzyme inhibitor with a γ-secretase modulator results in an additive reduction of Aβ production.
Strömberg K; Eketjäll S; Georgievska B; Tunblad K; Eliason K; Olsson F; Radesäter AC; Klintenberg R; Arvidsson PI; von Berg S; Fälting J; Cowburn RF; Dabrowski M
FEBS J; 2015 Jan; 282(1):65-73. PubMed ID: 25303711
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic Vaccine Based on Pyroglutamate-3 Amyloid β Generates Strong Antibody Response and Rescues Cognitive Decline in Alzheimer's Disease Model Mice.
Li G; Hu ZW; Chen PG; Sun ZY; Chen YX; Zhao YF; Li YM
ACS Chem Neurosci; 2017 Mar; 8(3):454-459. PubMed ID: 28292186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
